Views
1 year ago

gwpfdb7

gwpfdb7

22 Congressional Budget

22 Congressional Budget Office (CBO). Offsetting effects of prescription drug use on Medicare’s spending for medical services. Washington, DC: CBO; 2012. 23 Roebuck MC. Medical cost offsets from prescription drug utilization among Medicare beneficiaries. J Manag Care Spec Pharm. 2014;20(10):994-995. 24 Roebuck MC, Dougherty JS, Kaestner R, Miller LM. Increased use of prescription drugs reduces medical costs in Medicaid populations. Health Affairs. 2015;34(9):1586-93. 25 Roebuck MC, Liberman JN, Gemmill, Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff. 2011;30(1):91-9. 26 Seabury SA, Lakdawalla DN, Dougherty JS, Sullivan J, Goldman DP. Medication adherence and measures of health plan quality. Am J Manag Care. 2015;21(6):e379-89. 27 Carls GS, Roebuck MC, Brennan TA, Slezak JA, Matlin OS, Gibson TB. Impact of medication adherence on absenteeism and short-term disability for five chronic diseases. J Occup Environ Med. 2012;54(7):792-805. 28 Stuart BC, Dai M, Xu J, Loh FH, S Dougherty J. Does good medication adherence really save payers money? Med Care. 2015;53(6):517-23. 29 Feagan BG, Kozma CM, Slaton TL, Olson WH, Wan GJ. Healthcare costs for Crohn's disease patients treated with infliximab: A propensity weighted comparison of the effects of treatment adherence. J Med Econ. 2014;17(12):872-80. 30 Wan GJ, Kozma CM, Slaton TL, Olson WH, Feagan BG. Inflammatory bowel disease: Healthcare costs for patients who are adherent or non-adherent with infliximab therapy. J Med Econ. 2014;17(6):384-93. 31 Binion DG, Louis E, Oldenburg B, Mulani P, Bensimon AG, Yang M, Chao J. Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: A meta-analysis. Can J Gastroenterol. 2011;25(9):492-6. 32 Yermakov S, Davis M, Calnan M, et al. Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work-loss costs for patients with multiple sclerosis. J Med Econ. 2015;18(9):711-20. 33 National Community Pharmacists Association. Take as directed: A prescription not followed. http://www.ncpanet.org/pdf/adherence/ patientadherence-pr1206.pdf. Published December 15, 2006. Accessed March 2016. 34 Higashi T, Shekelle PG, Solomon DH, et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004;140(9):714-720 35 Eaddy MT, Cook CL, O'Day K, Burch SP, Cantrell CR. How patient cost-sharing trends affect adherence and outcomes: A literature review. PT. 2012; 37(1):45-55. 36 Kaiser Family Foundation and Health Research and Educational Trust. 2015 employer health benefits survey, page 162. http://kff.org/ health-costs/report/2015-employer-health-benefits-survey/. September 22, 2015. Accessed March 2016. 37 Avalere Health PlanScape © , a proprietary analysis of exchange plan features, December 2015. This analysis is based on data collected by Managed Markets Insight & Technology, LLC. 38 IMS Health. Emergence and impact of pharmacy deductibles: Implications for patients in commercial health plans. http://www. imshealth.com/en/thought-leadership/ims-institute/briefs/emergence-and-impact-of-pharmacy-deductibles:-implications-for-patientsin-commercial-health-plans. Published September 2015. Accessed March 2016. 39 Eaddy MT, Cook CL, O'Day K, Burch SP, Cantrell CR. How patient cost-sharing trends affect adherence and outcomes: A literature review. PT. 2012; 37(1):45-55. 40 Goldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291(19):2344-50. 41 Doshi JA, Li P, Ladage VP, Pettit AR, Taylor EA. Impact of cost sharing on specialty drug utilization and outcomes: A review of the evidence and future directions. http://www.ajmc.com/journals/issue/2016/2016-vol22-n3/Impact-of-Cost-Sharing-on-Specialty-Drug- Utilization-and-Outcomes-A-Review-of-the-Evidence-and-Future-Directions. Published March 17, 2016. Accessed March 2016. 42 Eaddy MT, Cook CL, O'Day K, Burch SP, Cantrell CR. How patient cost-sharing trends affect adherence and outcomes: A literature review. PT. 2012; 37(1):45-55. 43 Philipson TJ, Mozaffari E, Maclean JR. Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndrome. Am J Manag Care. 2010;16(4):290-2. 30 Improving Health Outcomes and Driving Value in Health Care

Impact on the Economy and Biomedical Ecosystem CHAPTER 3

you can read it here. - Ratbags
European Pharmaceutical Regulatory Law BOOT CAMP - Bristows
Best Practice Model - Association of the British Pharmaceutical ...
Making a Killing AMENDED - Animal Aid
I've Got Nothing to Lose by Trying It - Sense About Science
#SOTI16
WHO Drug Information Vol. 18, No. 2, 2004 - World Health ...
Fiction?
WHO-Medicines-Report-FINAL2015